Researchers launch trial to treat long COVID with drug used to block effects of opioids (News)
Researchers launch trial to treat long COVID with drug used to block effects of opioids ABC Gold Coast 20 December 2022 https://www.abc.net.au/news/2022-12-21/long-covid-treatment-trial-drug-low-dose-naltrexone/101770626?utm_source=abc_news_web&utm_medium=content_shared&utm_campaign=abc_news_web A team on Australia’s Gold Coast is collaborating with a doctor in Western Australia to run a clinical trial examining the impacts of low-dose naltrexone (LDN) on people suffering from long COVID. Earlier […]
Yukon government releases webpage with resources on long COVID (News)
Yukon government releases webpage with resources on long COVID Yukon News 08 December 2022 https://www.yukon-news.com/local-news/yukon-government-releases-webpage-with-resources-on-long-covid/ The Yukon government acknowledged long COVID exists in a wide range of diverse and long-term effects in some people who have been infected with COVID-19 when it announced the creation of a long COVID working group. The Yukon government released […]
Sandi – US: Multiple Sclerosis (LDN; low dose naltrexone)
Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I’m your host Linda Elsegood. I have an exciting lineup of guest speakers who are LDN experts in their field. We will be discussing low dose naltrexone and its many uses in autoimmune diseases, cancers, etc. Thank you for joining […]
‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever (News)
‘Promising Results’ for Low-Dose Naltrexone as Pain Reliever Pain News Network 15 November 2022 https://www.painnewsnetwork.org/stories/2022/11/15/promising-results-for-low-dose-naltrexone-as-pain-reliever Low-dose naltrexone (LDN) continues to get more recognition from the medical community as a treatment for some types of chronic pain. In smaller doses of 5mg or less, patients with fibromyalgia, interstitial cystitis, intractable pain and other chronic conditions have […]
Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions (News)
Low-Dose Naltrexone Promising for pain relief in fibromyalgia and host of chronic conditions Medical Dialogues 15 November 2022 https://medicaldialogues.in/medicine/news/low-dose-naltrexone-promising-for-pain-relief-in-fibromyalgia-and-host-of-chronic-conditions-102374 A new study found that low dose naltrexone (LDN) helped with chronic pain stemming from various conditions including fibromyalgia, Crohn’s disease, diabetic neuropathy, axial low back pain, rheumatoid arthritis, and complex regional pain syndrome. A review […]
Studies Aim to Find Long COVID Treatments (News)
Studies Aim to Find Long COVID Treatments VOA Learning English 31 October 2022 https://learningenglish.voanews.com/a/studies-aim-to-find-long-covid-treatments/6796700.html Researchers are studying treatments for the long-lasting effects of COVID infections, known as long COVID. They are excited to learn if naltrexone can offer similar helpful effects to millions of people suffering from health problems months after a coronavirus infection. Naltrexone […]
LDN for Treating Spike Protein Injuries, Diseases (News)
LDN for Treating Spike Protein Injuries, Diseases Epoch Health 26 October 2022 https://www.theepochtimes.com/health/low-dose-naltrexone-for-long-covid-and-spike-induced-injuries_4820584.html Due to the pandemic, long COVID and COVID vaccine-related syndromes have become a major health concern in society. Research has discovered that LDN might be a good treatment for long COVID and vaccine injuries. LDN reduces long COVID symptoms, including a significant […]
Long COVID Is Common and Scary! (News)
Long COVID Is Common and Scary! The People’s Pharmacy 04 October 2022 https://www.peoplespharmacy.com/articles/long-covid-is-common-and-scary When COVID-19 first appeared, it seemed as if there were just two outcomes for people who caught it: they died, or they got better. Now, though, many people who survive their bout with the coronavirus will become “long haulers.” There is growing […]
Should Doctors Consider Low Dose Naltrexone for Long COVID? (news)
Should Doctors Consider Low Dose Naltrexone for Long COVID? The People’s Pharmacy 20 October 2022 https://www.peoplespharmacy.com/articles/should-doctors-consider-low-dose-naltrexone-for-long-covid There is growing recognition that long COVID is becoming a serious challenge to health systems around the world. Doctors do not know what causes this condition in which symptoms persist for months or even years. There is currently no […]
Addiction drug shows promise lifting long COVID brain fog, fatigue (News)
Addiction drug shows promise lifting long COVID brain fog, fatigue Reuters 18 October 2022 https://www.reuters.com/business/healthcare-pharmaceuticals/addiction-drug-shows-promise-lifting-long-covid-brain-fog-fatigue-2022-10-18/ Researchers chasing long COVID cures are eager to learn whether low dose naltrexone (LDN) can offer similar benefits to millions suffering from pain, fatigue and brain fog months after a coronavirus infection. The drug has been used with some success to […]